GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IR-Med Inc (OTCPK:IRME) » Definitions » NonCurrent Deferred Liabilities

IRME (IR-Med) NonCurrent Deferred Liabilities : $0.00 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is IR-Med NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

IR-Med's non-current deferred liabilities for the quarter that ended in Mar. 2025 was $0.00 Mil.

IR-Med NonCurrent Deferred Liabilities Historical Data

The historical data trend for IR-Med's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IR-Med NonCurrent Deferred Liabilities Chart

IR-Med Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Liabilities
- - - - -

IR-Med Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

IR-Med NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of IR-Med's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


IR-Med Business Description

Traded in Other Exchanges
N/A
Address
Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400
IR-Med Inc is a development stage medical device company developing its technology through its Subsidiary and is utilizing Infra-Red-light spectroscopy (IR) combined with Artificial Intelligence (AI) technology platform to develop non-invasive devices for various medical indications, by detecting and measuring various biomarkers and molecules in the blood and in human tissue in real-time.